AgonOx

AgonOx, Inc. harnesses the power of the immune system to cure multiple cancers. Various combinations of immune cells are present in all tumors. We are identifying new immunotherapy targets by understanding the complexity of human tumor-infiltrating lymphocytes (TIL) isolated from several different tumor types. Through our close collaboration with the Earl A. Chiles Research Institute at the Providence Cancer Center, we have evaluated over a hundred tumor specimens obtained from surgeries.